Genomma Lab Financials
| LABB Stock | MXN 25.78 0.27 1.06% |
Genomma |
Please note, the imprecision that can be found in Genomma Lab's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genomma Lab Internacional. Check Genomma Lab's Beneish M Score to see the likelihood of Genomma Lab's management manipulating its earnings.
Genomma Lab Stock Summary
Genomma Lab competes with Gruma SAB, Alfa SAB, Kimberly Clark, Grupo Mxico, and Grupo Financiero. Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. GENOMMA LAB operates under Drug ManufacturersSpecialty Generic classification in Mexico and is traded on Mexico Stock Exchange. It employs 1451 people.| Instrument | Mexico Stock View All |
| Exchange | Mexican Exchange |
| ISIN | MX01LA010006 |
| Business Address | Av Antonio Doval |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.genommalab.com |
| Phone | 52 55 5081 0000 |
| Currency | MXN - Mexican Peso |
You should never invest in Genomma Lab without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Genomma Stock, because this is throwing your money away. Analyzing the key information contained in Genomma Lab's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Genomma Lab Key Financial Ratios
Genomma Lab's financial ratios allow both analysts and investors to convert raw data from Genomma Lab's financial statements into concise, actionable information that can be used to evaluate the performance of Genomma Lab over time and compare it to other companies across industries.| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 | |||
| Target Price | 22.41 | |||
| Beta | 0.53 | |||
| Z Score | 2.4 |
Genomma Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genomma Lab's current stock value. Our valuation model uses many indicators to compare Genomma Lab value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genomma Lab competition to find correlations between indicators driving Genomma Lab's intrinsic value. More Info.Genomma Lab Internacional is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genomma Lab Internacional is roughly 1.37 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Genomma Lab by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genomma Lab's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Genomma Lab Internacional Systematic Risk
Genomma Lab's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genomma Lab volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Genomma Lab Internacional correlated with the market. If Beta is less than 0 Genomma Lab generally moves in the opposite direction as compared to the market. If Genomma Lab Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genomma Lab Internacional is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genomma Lab is generally in the same direction as the market. If Beta > 1 Genomma Lab moves generally in the same direction as, but more than the movement of the benchmark.
Genomma Lab December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Genomma Lab help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genomma Lab Internacional. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genomma Lab Internacional based on widely used predictive technical indicators. In general, we focus on analyzing Genomma Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genomma Lab's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.87 | |||
| Information Ratio | 0.1498 | |||
| Maximum Drawdown | 10.44 | |||
| Value At Risk | (3.30) | |||
| Potential Upside | 3.39 |
Additional Tools for Genomma Stock Analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.